Half-year summaryof NATUREX's liquidity contract, June 2014


Pursuant to the liquidity contract granted to EXANE BNP PARIBAS regarding NATUREX shares, the following elements were in the liquidity account as of June 30, 2014, negotiation date: 


4,853 NATUREX shares
850 Subscription rights
523,937.00 euros 
It is reminded that the following assets appeared on the liquidity account as of December 31, 2013, settlement date:


8,642 NATUREX shares
269,721.00 euros 




If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.com







Naturex has been listed on Euronext Paris, Compartment B (MidCaps), since October 1996.

 








Total number of shares comprising the share capital: 9,182,307

ISIN FR0000054694



Naturex is a component of the CAC Small and Gaïa indexes.

Naturex is eligible for "long only" Deferred Settlement Service (SRD).

Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.


SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY








About NATUREX 

 

NATUREX is the global leader in specialty plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

 

NATUREX is the global leader in specialty plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.



 

Contacts

 






Thierry Lambert


Chair and Chief Executive Officer

Tel.: +33 (0)4 90 23 96 89 

t.lambert@naturex.com



Thierry-Bertrand Lambert


Chief Financial Officer

Tel.: +33 (0)4 90 23 96 89 

t.b.lambert@naturex.com





Carole Alexandre


Investor Relations

Tel.: +33 (0)4 90 23 78 28 

c.alexandre@naturex.com



Anne Catherine Bonjour


Actus Finance Press Relations

Tel.: +33 (0)1 53 67 36 93

acbonjour@actus.fr




Information réglementée
Rachat d'actions / contrat de liquidité :

- Information relative au contrat de liquidité
Communiqué intégral et original au format PDF :


http://www.actusnews.com/documents_communiques/ACTUS-0-36582-Half-year-summary-of-NATUREX_s-liquidity-contract_June-2014.pdf

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free



Quelle: Actusnews